Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Circulation|July 1, 1994
Intravenous Fluosol in the treatment of acute myocardial infarction. Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 Trial. TAMI 9 Research GroupT C Wall, R M Califf, J Blankenship, et al.Journal of the American College of Cardiology|October 1, 1996
Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic ComplicationsJ Lefkovits, J C Blankenship, K M Anderson, et al.Annals of Surgery|June 1, 1981
Influence of left ventricular aneurysm on survival following the coronary bypass operationE L Jones, J M Craver, J W Hurst, et al.The New England Journal of Medicine|November 17, 1994
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study GroupW S Weintraub, S J Boccuzzi, J L Klein, et al.Circulation|August 1, 1994
Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study GroupE M Ohman, B S George, C J White, et al.Journal of the American College of Cardiology|September 14, 2000
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?V Menon, J G Webb, L D Hillis, et al.The New England Journal of Medicine|February 23, 1995
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery diseaseC B Treasure, J L Klein, W S Weintraub, et al.Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.Circulation|October 1, 1990
Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 yearsJ D Talley, W S Weintraub, G S Roubin, et al.American Heart Journal|May 29, 2001
Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial RegistryJ G Webb, T A Sanborn, L A Sleeper, et al.Pageof 11